(Q36201684)

12 August 2017

1 reference

title

In pursuit of xenoreactive antibodies: where has it gotten us? (English)

1 reference

12 August 2017

William Parker

1

1 reference

PubMed ID

16033537

12 August 2017

Aaron P Lesher

series ordinal

2

1 reference

12 August 2017

1 August 2005

1 reference

Immunology & Cell Biology

12 August 2017

1 reference

12 August 2017

83

1 reference

12 August 2017

4

1 reference

12 August 2017

413-417

1 reference

Isohemagglutinins and xenoreactive antibodies: members of a distinct family of natural antibodies.

12 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01349.X

Potential implications of ABO blood group for vascular rejection in pig to human kidney xenotransplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01349.X

Human ABO blood group is important in survival and function of porcine working hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01349.X

Specificity of xenoreactive anti-Gal alpha 1-3Gal IgM for alpha-galactosyl ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01349.X

The human natural anti-Gal IgG. III. The subtlety of immune tolerance in man as demonstrated by crossreactivity between natural anti-Gal and anti-B antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01349.X

Characteristics of immunoglobulin gene usage of the xenoantibody binding to gal-alpha(1,3)gal target antigens in the gal knockout mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01349.X

The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01349.X

Immune exclusion and immune inclusion: a new model of host-bacterial interactions in the gut

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01349.X

Human secretory immunoglobulin A may contribute to biofilm formation in the gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01349.X

Immunoglobulin-mediated agglutination of and biofilm formation by Escherichia coli K-12 require the type 1 pilus fiber

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01349.X

Microbial biofilms in the gut: visualization by electron microscopy and by acridine orange staining

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01349.X

Getting a grip on things: how do communities of bacterial symbionts become established in our intestine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01349.X

Natural anti-Gal antibody as a universal augmenter of autologous tumor vaccine immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01349.X

A unique natural human IgG antibody with anti-alpha-galactosyl specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01349.X

Oligosaccharides and discordant xenotransplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01349.X

Xenoreactive natural antibodies in the world of natural antibodies: typical or unique?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01349.X

Acquired factor V inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01349.X

Topical thrombin-induced IgE-mediated anaphylaxis: RAST analysis and skin test studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01349.X

Exposure of mice to topical bovine thrombin induces systemic autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01349.X

Reduction of alpha-Gal expression by relocalizing alpha-galactosidase to the trans-Golgi network and cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01349.X

Targeted disruption of the alpha1,3-galactosyltransferase gene in cloned pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01349.X

Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01349.X

Production of alpha 1,3-galactosyltransferase-deficient pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01349.X

Inhibition of xenoreactive natural antibody production by retroviral gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01349.X

10.1111/J.1440-1711.2005.01349.X

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

16033537